Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
11/2000
11/09/2000WO2000066738A1 Process for producing recombinant insulin from novel fused protein
11/09/2000WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000WO2000066162A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000WO2000037638A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000036102A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/09/2000WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon
11/09/2000WO2000029428A3 5t4 tumour-associated antigen for use in tumour immunotherapy
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
11/09/2000CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000CA2372221A1 Methods for producing recombinant insulin from novel fusion proteins
11/09/2000CA2371596A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000CA2369964A1 Pesticidal fusions
11/09/2000CA2369747A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000CA2369371A1 Death domain containing receptor 5
11/08/2000EP1050582A2 Recombinant microorganisms expressing small rubber particle-associated protein
11/08/2000EP1049787A1 Multipurpose antibody derivatives
11/08/2000EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/08/2000EP1049778A2 Recombinant proteins derived from hgf and msp
11/08/2000EP1049777A1 Acpl dna and polypeptides
11/08/2000CN1272883A Adipocyte-specific protein homologs
11/08/2000CN1272882A Chimeric polypeptide comprising fragment B of shiga toxin and peptides of therapeutic interest
11/08/2000CN1058296C Antibody heteroconjugates for use in regulation lymphocyte activity
11/07/2000US6143297 Immunizing a mammals; forming antibodies
11/07/2000US6143273 Useful as immunosuppressants, as well as antibodies capable of preventing the specific binding of the lag-3 protein to major histocompatibility complex class ii molecules as immunostimulants
11/02/2000WO2000065340A1 Protein-protein interactions
11/02/2000WO2000039299A3 Streptococcus antigens
11/02/2000WO2000037642A9 Method of enhancing the biological activity of ligands
11/02/2000WO2000037640A9 Compositions and methods for the treatment of tumor
11/02/2000WO2000018932A3 Receptor based antagonists and methods of making and using
11/02/2000WO2000004926A3 Conjugates for treating inflammatory disorders and associated tissue damage
11/02/2000EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
11/02/2000EP1047791A1 Use of a proline-rich sequence to improve the fusogenic character of retroviral envelopes
11/02/2000EP1047788A2 Metastatic breast and colon cancer regulated genes
11/02/2000EP1047781A1 Il-18 receptors
11/02/2000EP1047780A1 Orphan receptors
11/02/2000CA2371006A1 Protein-protein interactions
10/2000
10/31/2000US6140081 Nucleotide binding polypeptide; for efficient use as diagnostic tools in gene therapy and transgenic cells
10/31/2000US6139846 Protein D- an IGD-binding protein of haemophilus influenzae
10/26/2000WO2000063395A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063373A1 A method of altering the properties of a membrane-associated protein by substitution of the transmembrane domain
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063250A1 Antibodies that recognize app cleaved by caspases and methods of use
10/26/2000WO2000062758A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000WO2000035481A3 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000024770A9 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2369820A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000CA2369762A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000CA2363984A1 Antibodies that recognize app cleaved by caspases and methods of use
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1045915A2 Regulation of biological events using multimeric chimeric proteins
10/25/2000EP1045904A1 Fatty acid transport proteins
10/25/2000EP1045861A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136954 Polypeptide which activates transcription in eucaryotic cells in the presence of antibiotic; for analysis of cellular proteins
10/24/2000US6136564 Process for the production of peptides by way of streptavidin fusion proteins
10/24/2000US6136527 Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
10/24/2000US6136313 Processes and intermediates for synthetic antibody derivatives
10/24/2000CA2005955C Synthetic hiv-like peptides, their compositions and uses
10/20/2000CA2271451A1 Variant c-terminal fragment of plasmodium falciparum msp-1
10/19/2000WO2000062071A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061618A1 Fab-EPITOPE COMPLEX FROM THE HIV-1 CROSS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5
10/19/2000WO2000061617A2 Transiently immortalized cells for use in gene therapy
10/19/2000WO2000061616A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2000WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000WO2000034308A3 Protein transduction system and methods of use thereof
10/19/2000WO2000032778A3 Methods and compositions for inhibiting neoplastic cell growth
10/19/2000CA2371929A1 Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5
10/19/2000CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000CA2365915A1 Recombinant toxin a/toxin b vaccine against clostridium difficile
10/19/2000CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same
10/19/2000CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000CA2364536A1 Fragments of virus protein 2 or 3 of polyoma virus, as vehicules for active substances
10/18/2000EP1044275A1 Mammalian matrix-type metalloprotease
10/18/2000EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE
10/18/2000CN1270635A Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these protein
10/18/2000CN1057535C Process for producing hydrophobic polypeptides proteins or peptides
10/18/2000CN1057534C Erythropoietin analogs
10/18/2000CN1057533C Method for producing clostridium perfringers vaccines
10/17/2000US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
10/17/2000US6133232 Protein or fragment having neurotrophic, growth or differentiation factor activity in xenopus embryos
10/17/2000US6133049 Methods, agents and kits for detection of organophosphorus compounds
10/17/2000US6133011 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
10/17/2000US6132992 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
10/17/2000US6132991 Human interleukin-3 (IL-3) variant fusion proteins
10/17/2000US6132734 Cloning of mite allergens
10/17/2000US6132722 Recombinant antibody-enzyme fusion proteins
10/12/2000WO2000060090A1 Compounds and methods for the diagnosis and treatment of b. microti infection
1 ... 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 ... 295